BIOMAT Database Logo BIOMAT Database Logo

Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. 1998

G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Department of Emergency Medicine, University La Sapienza, Rome, Italy.

Several factors suggest that endogenous benzodiazepines and gamma-amino-butyric acid may be involved in pathophysiology of hepatic encephalopathy (HE). Contrasting opinions exist on the therapeutic efficacy of flumazenil in the treatment of HE. This study was planned to assess the efficacy of flumazenil by a double-blind, placebo-controlled, crossover design in a large and selected population of cirrhotic patients in stage 4a HE admitted to intensive care units over a 4-year period. Out of 236 patients selected for the study, 132 received flumazenil, whereas 131 patients received placebo. Improvement of the neurological score was documented in 31 patients (23%) of flumazenil group and in two patients (1.5%) of placebo group (p < 0.001) during the first study period, whereas during the crossover period, improvement of the neurological score was documented in seven patients (5.3%) of the flumazenil group and in none of the placebo group (p = 0.022). Improvements in EEG tracings were observed in 44 patients (33.3%) of flumazenil group and in five patients (3.8%) of placebo group (p < 0.001) during the first study period; during the crossover period, improvements in EEG tracings were observed in 10 patients (7.5%) of the flumazenil group and in two patients (1.5%) of the placebo group (p = 0.040). The presence of benzodiazepines was detected in the serum of three responders and in two non-responders. The presence of diazepam and NN-desmethyl diazepam was documented in two responders; prior intake of synthetic diazepam was later confirmed in these patients. The results of our study suggest that flumazenil is beneficial only in a selected subset of cirrhotic patients with severe HE; the applicability of this treatment to unselected patients with hepatic coma or to cirrhotic patients with less severe HE still remains to be determined.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
January 1994, Hepatology (Baltimore, Md.),
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Use of flumazenil in intoxicated patients with coma. A double-blind placebo-controlled study in ICU.
January 1990, Intensive care medicine,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study.
February 2011, Nutrition (Burbank, Los Angeles County, Calif.),
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Lipid control with low-dosage simvastatin in patients with moderate hypercholesterolaemia. An Italian multicentre double-blind placebo-controlled study.
July 1992, European heart journal,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
January 1997, Alcohol and alcoholism (Oxford, Oxfordshire),
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
April 1995, European journal of gastroenterology & hepatology,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
May 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.
January 2014, Hepatology research : the official journal of the Japan Society of Hepatology,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
September 2006, International psychogeriatrics,
G Barbaro, and G Di Lorenzo, and M Soldini, and M Marziali, and G Bellomo, and G Belloni, and B Grisorio, and M Annese, and D Bacca, and G Barbarini
Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study.
December 1990, BMJ (Clinical research ed.),
Copied contents to your clipboard!